ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664266 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664266; 2) Community: the network communities that were significantly associated with the response to NSC 664266; 3) Molecule: the relationships between components within communities and NSC 664266; 4) MDR: the compounds that were significantly associated with the NSC 664266.

NSC Compound Enrichment Correlation
NSC 645161 Null 0.0241085022307781 0.37879989
NSC 659853 2-Methoxy-.beta.-estradiol 0.0241085022307781 0.39320478
NSC 301457 Cycloalkannin 0.0247979034812109 0.46427989
NSC 606499 Camptothecin Derivative 0.0247979034812109 0.10796367
NSC 625492 Bismuth, dichloro(1-piperidinylcarbamodithioato-S,S')-, (T-4)- 0.0247979034812109 0.47820994
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0247979034812109 0.63326804
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.0247979034812109 0.53521981
NSC 638241 Null 0.0247979034812109 0.47425734
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0247979034812109 0.49015342
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.0247979034812109 0.41528819
Total:170  Current:109    [First] [Prev] [Next] [Last]